Status:
UNKNOWN
High Frequency Percussive Ventilation in COVID-19 Patients
Lead Sponsor:
University Magna Graecia
Conditions:
COVID-19
Acute Respiratory Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
High frequency percussive ventilation (HFPV) is used in patients with underlying pulmonary atelectasis, excessive airway secretions, and respiratory failure. HFPV is a non-continuous form of high-freq...
Eligibility Criteria
Inclusion
- acute respiratory failure with a nasal swab positive for SARS-CoV-2
- need for high-flow oxygen through nasal cannula
Exclusion
- life threatening cardiac arrythmia
- pneumothorax
- acute spinal injury
- chest trauma
- hemodynamic instability
- chest or abdominal surgery in the previous 7 days
- pregnancy
- enrollment in other study protocols
Key Trial Info
Start Date :
May 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05358184
Start Date
May 15 2022
End Date
June 30 2022
Last Update
May 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.